Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NoseOption AB
AB
Active
Org 5568612294
Surbrunnsgatan 42, 113 48
Stockholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 14 years old
7 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
NoseOption AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
4M
9M
13M
17M
5M
2020
4M
2021
7M
2022
9M
2023
15M
2024
EBITDA
SEK millions
0M
-4M
-8M
-11M
-15M
-6M
2020
-8M
-33%
2021
-8M
0%
2022
-12M
-50%
2023
-8M
+33%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
4 615
3 932
6 726
9 287
15 040
Staff expenses
—
—
—
—
—
EBITDA
−5 787
−7 771
−7 711
−11 649
−7 690
Depreciation & amort.
−1 626
−2 041
−6 150
−1 199
−1 446
EBIT
−7 413
−9 812
−13 861
−12 848
−9 136
Net financials
−99
−386
−277
−17
−6
Profit before tax
−7 512
−10 198
−14 138
−12 865
−9 142
Tax
−0
−0
−3 686
−0
−0
Net profit
−7 512
−10 198
−17 824
−12 865
−9 142
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
21 559
21 939
10 504
11 370
16 682
Equity
16 883
16 717
7 132
7 766
8 622
Long-term debt
3 500
3 461
804
367
0
Short-term debt
1 176
1 761
2 569
3 237
8 060
Total debt
4 676
5 222
3 373
3 604
8 060
Financial ratios
5-year trend
EBITDA margin
-51.1%
This company
15.8%
Market median
-423% vs market
2020
2024
Equity ratio
51.7%
This company
38.2%
Market median
+35% vs market
2020
2024
Return on equity
-106.0%
This company
18.4%
Market median
-676% vs market
2020
2024
Net profit margin
-60.8%
This company
8.1%
Market median
-851% vs market
2020
2024
Asset turnover
0.90×
This company
1.12×
Market median
+20% vs market
2020
2024
Debt / equity
0.93×
This company
0.62×
Market median
+50% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on NoseOption AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
